Explore

Dr. C. Ola Landgren to Receive PMWC Pioneer Award for Advancing Minimal Residual Disease in Multiple Myeloma

Dr. C. Ola Landgren to Receive PMWC Pioneer Award for Advancing Minimal Residual Disease in Multiple Myeloma

C. Ola Landgren, M.D., Ph.D., director of Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, will receive the Precision Medicine World Conference (PMWC) Pioneer Award in January 2027. This recognition is for his significant contributions to advancing minimal residual disease (MRD) as an earlier and more precise measure of treatment effectiveness in multiple myeloma. MRD refers to the tiny number of cancer cells that remain during remission, detectable only by highly sensitive laboratory methods. Dr. Landgren's work has been instrumental in helping new therapies demonstrate effectiveness more quickly, potentially accelerating their availability to patients. His team is also leading research into bispecific T-cell therapies, including strategies to safely deliver these treatments and manage side effects like cytokine release syndrome. This research extends to other cancers, such as lymphoma and rare gynecologic neuroendocrine cancers, demonstrating a continuous cycle of measurement, learni...

City of Hope Receives $11 Million Gift to Advance Personalized Cancer Treatment and AI Research

City of Hope Receives $11 Million Gift to Advance Personalized Cancer Treatment and AI Research

City of Hope, a prominent cancer research and treatment organization in the United States, has been granted an $11 million philanthropic gift from the Simms/Mann Family Foundation. This substantial donation is earmarked to accelerate research in personalized cancer prevention, diagnosis, and treatment. The investment will specifically support advancements in genomics, artificial intelligence (AI), and microbiome science. A key outcome of this gift will be the establishment of the Simms/Mann Family Foundation Precision Oncology Program in Southern California, creating a permanent funding source for high-priority research projects and emerging scientific opportunities. Additionally, the gift will fund two endowed academic chairs: one for cancer microbiome research and another for clinical cancer genomics, with the latter to be filled through a recruitment process.

Reps. Carson and Wittman Introduce Bipartisan Bill for National Young Adult Cancer Strategy

Reps. Carson and Wittman Introduce Bipartisan Bill for National Young Adult Cancer Strategy

Reps. André Carson (D-Ind.) and Rob Wittman (R-Va.) have introduced bipartisan legislation in the U.S. House of Representatives to establish the Asal Sayas National Strategy on Young Adult Cancers Act. This bill aims to create the first national strategy specifically addressing cancers in adults aged 18 to 49. The Colorectal Cancer Alliance is leading a national effort to gather support for this bill, encouraging patients, caregivers, advocates, and organizations to sign up and help ensure its passage. The proposed legislation would mandate the National Institutes of Health (NIH) to develop a comprehensive strategy within 18 months of the bill becoming law. This strategy would involve mapping current research, launching a national education campaign to raise awareness of symptoms and risk factors, setting research priorities for causes, biomarkers, early detection, and new treatments, and reducing barriers to clinical trial participation for young adults. Companion legislation was previously introduced in ...

Congressman André Carson Introduces Bipartisan Legislation for National Strategy on Young Adult Cancers

Congressman André Carson Introduces Bipartisan Legislation for National Strategy on Young Adult Cancers

Congressman André Carson (D-Ind.) has introduced bipartisan House legislation aimed at creating the first national strategy to address cancers in adults aged 18 to 49. The bill, named the Asal Sayas National Strategy on Young Adult Cancers Act, was co-sponsored by Representative Rob Wittman (R-Va.). This initiative seeks to direct the National Institutes of Health (NIH) to develop a comprehensive plan within 18 months of the bill becoming law. The strategy would involve mapping current research, launching a national education campaign to improve symptom recognition, setting research priorities for causes, biomarkers, and early detection, and reducing barriers to clinical trials for young adults. Additionally, it aims to address the specific needs of young patients and caregivers, including fertility, mental health, and work-related challenges, and establish an online federal resource hub. The Colorectal Cancer Alliance is actively rallying support for this legislation, emphasizing the urgent need for a nat...

Lustgarten Foundation Scientific Advisory Board Outlines Strategic Direction for Pancreatic Cancer Treatments

Lustgarten Foundation Scientific Advisory Board Outlines Strategic Direction for Pancreatic Cancer Treatments

The Lustgarten Foundation, the largest private funder of pancreatic cancer research, recently convened its Scientific Advisory Board (SAB) to establish the strategic direction for the next generation of pancreatic cancer treatments. Following a year of significant scientific progress, including the FDA approval of the RAS-targeted therapy RASONQUE™ (daraxonrasib), the meeting focused on building upon these breakthroughs to develop more effective and durable treatments. Key areas of discussion included advancing methods to measure treatment response, understanding treatment failure and resistance, identifying new therapeutic targets and combinations, advancing prevention and interception strategies, and innovating clinical trial design. A central theme was the importance of integrating clinical observations, biological insights, and new methods for measuring treatment response to guide more personalized treatment strategies. The Foundation awarded $22.8 million in new research funding in fiscal year 2026, a...

Steve and Marian Mosites Family Foundation Funds Precision Medicine Research in Head and Neck Cancer

Steve and Marian Mosites Family Foundation Funds Precision Medicine Research in Head and Neck Cancer

The Department of Otolaryngology-Head & Neck Surgery has received a significant gift from the Steve and Marian Mosites Family Foundation. This donation is specifically allocated to advance precision medicine research in head and neck cancer, funding two projects through the Mosites Precision Medicine Awards for 2026. The award recipients are Matthew Spector, MD, FACS, for his project titled 'Personalized Implant-Radiation Strategies for Head and Neck Cancer Reconstruction,' and Lazar Vujanovic, PhD, for his project 'Defining the Postoperative Immune Landscape in Oral Cavity Cancer via Surgical Drain Fluid.' Dr. Spector's research aims to explore personalized mandibular reconstruction using novel CFR-PEEK implants to improve radiation delivery and healing. Dr. Vujanovic's project will study the immune environment immediately after surgery using surgical drain fluid to understand anti-tumor immune responses and identify patients who might benefit from more personalized treatments. The initiative honors Maria...

Vikings reacquire Kirk Cousins in deadline deal with Raiders

Vikings reacquire Kirk Cousins in deadline deal with Raiders

By Field Level Media Nov 10 (Field Level Media) - Kirk Cousins is headed back to the Minnesota Vikings in a deadline trade with the Las Vegas Raiders completed Tuesday afternoon.

Raiders trade QB Kirk Cousins to Vikings, Seahawks will face Fernando Mendoza

Raiders trade QB Kirk Cousins to Vikings, Seahawks will face Fernando Mendoza

Fernando Mendoza will make his NFL debut against the reigning champs

Precision for Medicine Seeks Clinical Trial Manager for Oncology Research

Precision for Medicine Seeks Clinical Trial Manager for Oncology Research

Precision for Medicine Seeks Clinical Trial Manager for Oncology Research

NIH Extends $6.6 Million Grant to UConn Pepper Center for Aging Research Through 2031

NIH Extends $6.6 Million Grant to UConn Pepper Center for Aging Research Through 2031

The National Institute on Aging, part of the National Institutes of Health (NIH), has extended a significant grant to the University of Connecticut’s (UConn) Claude D. Pepper Older Americans Independence Center. The $6.6 million grant will support the Center's research and initiatives through 2031. This funding aims to enhance the understanding of the human aging process, with a focus on improving the quality of life for older adults. UConn's Pepper Center, one of only 15 nationwide, was initially established in 2021 with a $7 million NIH grant. The Center conducts multidisciplinary research into the heterogeneity of aging, utilizing various strategies including basic bench research, observational human subject studies, clinical trials, and analysis of large population-level datasets. Dr. George Kuchel and Dr. Richard Fortinsky serve as co-directors, with Dr. Lisa Barry joining as a co-lead Principal Investigator for the expanded phase.

Seattle Area Sees 709% Surge in Millionaire Renters Since 2020 Amid Tax Fears and Tech Uncertainty

Seattle Area Sees 709% Surge in Millionaire Renters Since 2020 Amid Tax Fears and Tech Uncertainty

Seattle Area Sees 709% Surge in Millionaire Renters Since 2020 Amid Tax Fears and Tech Uncertainty

Week 10 fantasy tight end rankings: Top TE streamers, starts

Week 10 fantasy tight end rankings: Top TE streamers, starts

Kansas City's Travis Kelce scored his first touchdown since Week 3 in a rout of the Jets, but he's continued to produce all season as the overall TE5.